PCN382 TRASTUZUMAB IN THE TREATMENT OF HER2-POSITIVE EARLY ANDLOCALLY ADVANCED BREAST CANCER: THE FIRST HTA REPORT OF INEAS-TUNISIA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.577
https://www.valueinhealthjournal.com/article/S1098-3015(19)32955-9/fulltext
Title :
PCN382 TRASTUZUMAB IN THE TREATMENT OF HER2-POSITIVE EARLY ANDLOCALLY ADVANCED BREAST CANCER: THE FIRST HTA REPORT OF INEAS-TUNISIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32955-9&doi=10.1016/j.jval.2019.09.577
First page :
Section Title :
Open access? :
No
Section Order :
10500